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Renal endothelin gene expression is increased in remnant kidney and
correlates with disease progression. We previously demonstrated that
urinary endothelin excretion is increased in rats with extensive renal
mass reduction, a model of progressive renal disease. Here we explored
whether the increased urinary endothelin in this model were due to
induction of renal pre-pro-endothelin-l gene and whether changes in
endothelin synthetic pathway correlated with the development of
glomerulosclerosis. Four groups of rats with renal mass reduction and
four groups of sham-operated control rats were studied 7, 30, 60 and 120
days after the surgical procedure. Urinary protein excretion in renal
mass ablation animals did not differ from controls at seven days, but
was already significantly elevated (P < 0.01) 30 days after surgery.
Then proteinuria progressively increased in rats with remnant kidney at
values above 400 mg/day at day 120. Serum creatinine concentration
also progressively increased with time in renal mass ablation rats,
unlike sham-operated animals, and values were significantly different (P
< 0.01) at each of the points considered. Rats with renal mass
reduction, unlike sham-operated animals, developed focal glomerulo-
sclerosis that affected 8% of glomeruli at day 30, and 24% of glomeruli
at day 120, Seven days after renal mass reduction renal pre-pro-
endothelin-l (pre-pro ET) mRNA was comparable to that of sham-
operated rats, while a 2.5-, 5- and fourfold increase in 2.3 Kb pre-
proET-l transcript was observed at 30, 60 and 120 days, respectively.
Urinary excretion of endothelin was significantly elevated (P < 0.01) in
rats with renal mass reduction with respect to sham-operated rats,
starting from 30 days after surgery and increased further thereafter. A
significant correlation (P < 0.01) was found between urinary endothe-
ljn-l excretion values and the percent of glomeruli affected by glomer-
ulosclerosis. We conclude that the progression of renal disease after
surgical ablation of renal mass is associated with an increased renal
endothelin-l gene expression together with an excessive urinary excre-
tion of the corresponding protein. It is speculated that endothelin may
mediate glomerular structural abnormalities associated with the pro-
gression of renal disease in this model.
Endothelin, first isolated and purified from porcine aortic
endothelial cells, is a potent vasoconstrictor peptide of 21
amino acids encoded by a single gene [1]. Expression of
pre-pro-endothelin-l mRNA in porcine aortic endothelium is
increased by a variety of chemical and mechanical stimuli
including the calcium ionophore A23187, thrombin, epineph-
rifle, transforming growth factor-p and enhanced shear stress
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[1—3]. Beside aortic endothelium, cultured bovine glomerular
endothelial and human and rat mesangial cells constitutively
express pre-pro-endothelin gene and release the corresponding
protein in the cell supernatant [4-6]. By virtue of its vasoactive
properties, endothelin may play a major role in the control of
renal hemodynamics in normal and, possibly more importantly,
in disease conditions. Furthermore, the recent observation that
endothelin induces mesangial cell proliferation and contraction
[7—9] and increases the expression of extracellular matrix pro-
tein mRNA [101 has raised interest in its potential role in renal
disease progression. We have previously documented [ill that
renal cortical tissue and isolated glomeruli from animals after
extensive reduction of renal mass generate significantly more
endothelin than the control kidney. This was associated with an
increased urinary excretion of endothelin, which is likely to
reflect renal synthesis of the peptide [11] in rats with remnant
kidney as compared to sham-operated animals.
The present study was designed to explore whether the
increased urinary excretion of endothelin in this model were
due to induction of renal pre-pro-endothelin-1 gene and whether
changes in endothelin synthetic pathway correlated with the
development of glomerulosclerosis.
Methods
Male Sprague-Dawley rats (Charles River Italia S.p.A.,
Calco, Italy) weighing 290 to 330 g at the start of the experiment
were used in these studies. All animals were allowed free access
to standard rat laboratory diet containing 20% protein by
weight, and tap water.
Experimental design
Renal mass was reduced by removal of right kidney and
ligation of two or three branches of the left renal artery under
ether anesthesia according to Olson [121. A preliminary exper-
iment was carried out in seven rats 60 days after the surgical
procedure and in seven sham-operated animals. Subsequently,
four groups of rats were considered which were studied at 7 (N
= 10), 30 (N = 10), 60 (N 8) and 120 (N = 10) days. As
controls four groups of five rats each were subjected to sham
operation with manipulation of pedicles and followed for 7, 30,
60 and 120 days. At the end of the experimental periods 24-hour
urine samples were collected in metabolic cages for determina-
tion of protein and endothelin excretion and blood withdrawn
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from the tail vein for hematocrit and serum creatinine determi-
nations. At sacrifice, kidneys were excised and renal tissue was
processed for RNA extraction and histological evaluation.
Oligonucleotides
Oligos were synthesized in a 380 B automatic DNA synthe-
sizer (Applied Biosystems). The sense-orientation primer (oh-
go 1: 5'GACATCGTCGACATGGATFATTTTCCCGTGATC)
and the antisense orientation primer (oligo 2:S'GTCAGCGTC-
GACCTGTAGTCAATGTGCTCGGTT) having Sal I linker at
their 5' ends, were based on the published sequence of the rat
endothehin-l cDNA [13].
PCR cloning of the rat endothelin-1 cDNA
Ten to 20 ig of rat kidney RNA were incubated, after
annealing, at 42°C for two hours in a 40-pi reverse transcription
mixture containing: 50 mi Tris HC1 pH 8.3; 60mM KCI; 10mM
MgC12; 1 mivi dithiothreitol, 50 tg/ml actinomycin D, 10 units of
RNasin (Promega), 0.5 mrt dNTPs, 1.6 g oligo d(T) and 20
units of AMW reverse transcriptase (Boehringer). The mixture
was then extracted with phenol/chloroform and ethanol precip-
itated. The resulting cDNA/RNA pellet was resuspended in 40
l H20. PCR was performed at a final concentration of lx PCR
buffer (10 mti Tris-HCI pH 8.3; 50 mrvi KCI; 2 mM MgCl2), 50
M dNTP, 0.1 /LM sense and antisense oligos (oligo 1 and oligo
2), 2.5 units of Taq DNA Polymerase (Perkin-Elmer/Cetus) in a
total volume of 100 d. Amplification cycle was: one minute at
60°C, 2.5 minutes at 72°C and one minute at 94°C. The cycle
was repeated 30 times. The amplified product of the expected
size was Sal I digested, gel purified and inserted into pTZl9
vector (Pharmacia). The sequence of our cDNA fragment was
identical to the region included between nucleotide 1 and
nucleotide 615 of rat endothelin-1 cDNA published by Sakurai
et al [13]. This was also confirmed by restriction mapping.
RNA isolation from rat kidneys and Northern blot analysis
Total RNA from rat kidneys was prepared by isothiocyanate
extraction and centrifugation throughout cesium chloride [14],
poly(AY RNA was then selected by ohigo(dT)-cellulose column
chromatography (Clontech mRNA separator). Previous work
showed the presence of a 2.3 Kb endothelin-l transcript in
mRNA from rat kidney of very low intensity [13]. Thus, we
collected and pulled together portions of remnant kidneys of
renal mass ablation animals and, after mRNA extraction, we
loaded up to 15 g rat kidney mRNA for each Northern
analysis. mRNA (10 to 15 g) from renal mass reduction and
sham-operated rats was fractionated on 1.2% formaldehyde
agarose gel and blotted onto synthetic membranes (Gene
Screen Plus, New England Nuclear, Boston, Massachusetts,
USA). Rat endothelin-l cDNA was labeled by a random-primed
labeling method using (alpha-32P)dCTP [15]. Membranes were
hybridized with 32P-labeled pre-pro-endothelin- 1 probe and
with mouse a-actin eDNA [16], taken as internal standard of
equal loading of the samples on the membrane, and exposed to
X-ray film for autoradiography. Differential expression in renal
mass reduction, as compared with sham-operated animals, was
calculated using densitometric analysis.
Endothelin extraction and assessment in urine
Five milliliter aliquots of each urine collection were extracted
as previously described [11], lyophilized and stored at —20°C
until use. Extracted samples were resuspended in phosphate
buffer (pH 7.2) containing 0.1% Triton X-lOO and 0.3% albumin
(RIA buffer) immediately before the assay.
After assessment of total recovered radioactivity (range: 75
to 85%), endothelin was assayed by radioimmunoassay at a final
dilution of 1:5. Either standard or unknown samples were
mixed with the antiserum (Peninsula, Belmont, California,
USA; final dilution 1:72,000) and incubated for 24 hours at 4°C,
then 12,000 cpm of 1251-endothelin was added and the incuba-
tion prolonged for 24 hours at 4°C. Separation of free from
antibody-bound labeled peptide was achieved by addition of an
immunoprecipitating mixture consisting of a sheep anti-rabbit
IgG and polyethylene glycol for 30 minutes at room temperature
and subsequent centrifugation at 1700 x g for 20 minutes.
Supernatants were removed by aspiration with a vacuum pump
and pellet radioactivity detected by a gamma counter (Beck-
man, Irvine, California, USA). Results were expressed as
pg/day. The detection limit of the assay was 0.4 pg/tube,
nonspecific binding did not exceed 2% of total radioactivity.
Cross reactivity of anti-endothelin antibody was as follows:
endothelin-2, 46.9%; endothelin-3, 17%; and Big endothelin-l,
9%. Intra- and interassay variability averaged 9% and 14%.
Validation of RIA measurements was performed by comparison
with different antisera and by recovery of cold endothehin- 1
added to urine. For the sake of simplicity immunoreactive
endothehin will be called endothelin.
Pathological studies
Fragments of kidneys were fixed for 12 hours in Dubosq-
Brazil, dehydrated in alcohol, and embedded in paraffin. Sec-
tions (3 Lm) were stained with hematoxylin and eosin, Mas-
son's trichrome, periodic acid-Schiff reagent (PAS stain) and
Wilder's reticulin, Sections including superficial and juxtamed-
ullary glomeruli were evaluated. For each animal, at least 150
glomeruli were examined and the percentage of glomeruli
presenting focal or global glomerulosclerosis was determined.
Analytical
Urinary protein concentration was determined by the
Coomassie blue dye-binding with BSA as standard [17]. Serum
creatinine was measured by alkaline picrate method [18].
Statistical analysis
All results are expressed as means SD. Data were analyzed
by analysis of variance and subsequent multiple comparisons
were performed using SAS program [19]. Protein and endothe-
un urinary excretion data were log-transformed before statisti-
cal analysis. Urinary endothelin excretion was correlated with
percent of sclerotic glomeruhi by linear regression analysis.
Statistical significance was defined as P < 0.05.
Results
Table 1 shows results of proteinuria, renal function and
gtomerulosclerosis in rats with renal mass ablation as compared
to sham-operated animals studied at different time intervals
from the surgery. At day 7 urinary protein excretion was
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comparable in renal mass reduction and sham-operated ani-
mals. Massive proteinuria appeared by day 30 after surgery in
animals with renal mass ablation and was significantly (P <
0.01) different from controls. At day 120 a further increase in
urinary protein excretion was observed in renal mass reduction
rats at values which were significantly higher (P < 0.01) than
those observed at days 30 and 60. Serum creatinine concentra-
tion was significantly higher in rats with renal mass ablation as
compared to sham-operated animals at each time point consid-
ered. Within the group of animals with reduction of renal mass
values of serum creatinine concentrations were significantly
higher (P < 0.01) at day 30 versus day 7 and progressively
increased thereafter. At 30 days after surgery rats with renal
mass ablation developed glomerulosclerotic changes which
affected an average of 8% of glomeruli. Sham-operated animals
were completely free of sclerosis at that time. At 60 and 120
days after surgery, percent of glomeruli affected by sclerotic
changes increased in animals with reduction of renal mass,
reaching an average of 19% and 24%, respectively. No glomer-
ulosclerosis developed in sham-operated animals at any time
point considered up to the end of the study.
The time course of pre-pro-endothelin-1 gene induction dur-
ing the evolution of the disease in rats with remnant kidney is
given in Figure 1. Densitometric analysis of the autoradio-
graphic signals shows that endothelin-1 transcript levels were
comparable in rats with renal mass reduction and controls when
studied at seven days. Transcriptional rates of pre-pro-endo-
thelin-1 gene progressively increased at 30 and 60 days after
renal ablation, the mRNA levels being 2.5- and fivefold higher
than corresponding controls, respectively. No further increase
in endothelin-1 transcript was observed in rats 120 days after
surgical procedure. Figure 2 shows a representative Northern
blot analysis of a single 2.3 Kb endothelin-1 mRNA transcript
from kidneys studied 60 days after surgery or sham operation.
Consistent with gene expression data, the urinary excretion
of endothelin was significantly elevated (P <0.01, Table 1) in
rats with renal mass reduction in respect to sham-operated rats,
Fig. 2. Endothelin gene expression in kidney homogenate from sham-
operated (control) and renal mass reduction (RMR) rats, Experiments
were performed 60 days after the surgical procedure. Messenger RNA
(10 g) obtained from kidneys of 7 RMR and 7 control rats was blotted
onto synthetic membranes, which were hybridized with rat endothelin-1
and mouse a-actin cDNAs.
starting from 30 days after surgery. Thereafter values progres-
sively increased with time in animals with remnant kidney but
not in sham-operated animals. As it is depicted in Figure 3,
linear regression analysis indicates that values for urinary
endothelin excretion parallel structural injury, with a significant
correlation (P < 0.01) between values for endothelin excretion
and percentage of sclerolic glomeruli in individual rats.
Discussion
We have found that endothelin gene expression by kidney
homogenates from animals with renal mass ablation progres-
sively increased with time in the remnant kidney model up to
four- to fivefold as compared to sham-operated animals. More-
over, the results of the present study confirm and extend
previous observation that urinary endothelin excretion values
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Fig. 1. Densitometric analysis of autoradiographic signals showing
pre-pro-endothelin mRNA expression in kidneys of rats studied at
d{/ferent time intervals from surgery. The optical density of the auto-
radiographic signals was quantitated and calculated as the ratio of
pre-pro-endothelin to actin mRNA. The mRNA level of each control
tissue was assigned the number 1.0 and the intensity of the transcripts
of reduction of renal mass kidneys was calculated relative to the mRNA
levels of control kidneys of the corresponding time.
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Table 1. Renal function parameters, urinary endothelin excretion (U-ET) and focal glomerulosclerosis in rats with renal mass reduction
(RMR) and sham-operated (controls) at different times after surgery
Group Day
Proteinuria
mg/day
Serum
creatinine
mg/dl
Glomeruli with
sclerotic changes
% (range)
U-ET
pg/day
RMR 7 29 14 1.4 0.2k 1(0—2) 31.5 9.6
RMR 30 221 171a 1.7 8 (0—25) 88.3 36.O'
RMR 60 238 118C 1.5 0.4a 19 (7—37) 175.8 1O4.6
RMR 120 465 248 1.9 o.4 24 (6—63) 264.1 1l6.7'
Control 7 16 3 0.6 0.1 0 28.8 13.8
Control 30 18 2 0.6 0.1 0 32.5 6.6
Control 60 27 16 0.6 0.1 0 35.4 2.9
Control 120 27 4 0.7 0.1 0 37.6 3.7
Values are expressed as mean SD.
a P < 0.01 versus control at corresponding time
b P < 0.01 versus RMR at 7 days
P < 0.02 versus RMR at 30 daysd P < 0.02 versus RMR at 60 days
P < 0.01 versus RMR at 60 days
are enhanced in animals with renal mass reduction and also
progressively increase with time and parallel signs of renal
injury including proteinuria and glomerulosclerosis [11]. Taken
together, these results seem to consistently indicate that pro-
gressive renal disease which follows renal mass reduction is
associated with changes in the regulation of endothelin gene
followed by an increased renal synthesis of the corresponding
protein which can be measured in the urine.
Several explanations may be provided for such findings: one
is that extensive ablation of renal mass is associated with major
hemodynamic changes due to blood flow redistribution in
remnant glomeruli. Increased blood flow is one of the major
determinants of shear stress and data are available to indicate
that shear stress stimulates the expression of endothelin gene
[31. Moreover, platelet accumulation within the glomerular tuft
occurs at a very early stage of the remnant kidney model [20]
followed by platelet activation and microvascular thrombosis.
Of interest to interpret our present findings is the recent
• evidence that platelets stimulate in a time-dependent manner
the expression of gene encoding endothelin- 1 and the release of
the mature peptide from endothelial cells. A second possibility
that may explain changes in the endothelin synthetic pathway in
glomerular diseases starts from the observation that mesangial
cells constitutively express endothelin gene [5, 6]. A recent
study [4] has also documented that exposure of mesangial cells
to inflammatory mediators such as transforming growth fac-
tor-/3, the thromboxane mimetic U46619 and thrombin increase
• specific endothelin mRNA transcripts three- to sixfold over the
basal value. Since most renal diseases, including the remnant
kidney model, are associated with an influx of inflammatory
cells into the kidney, it is conceivable that mediators released
by infiltrating neutrophils and macrophages act as a stimulus for
mesangial cell to increase endothelin synthesis. Actually, in
vitro experiments have documented that endothelin stimulates
mitogenesis of cultured rat mesangial cells coupled with the
increased expression of proto-oncogene c-fos and c-myc [7]
which normally precedes cell proliferation. Proliferating mesan-
gial cells up-regulate extracellular matrix proteins which may
favor the development of glomerular scarring [21, 221. Further-
more, data are available that in rat mesangial cells endothelin
increases expression of mRNA for collagen type I, III and IV,
and laminin [101. Our data that increased endothelin-1 gene
expression in the kidney of animals with remnant kidney
correlates with focal and segmental glomerulosclerosis are quite
consistent with the recent finding of Osada et a! [23] who found
increased endothelin- 1 mRNA levels in glomeruli and medulla
from animals with focal glomerulosclerosis induced by puromy-
cm aminonucleoside.
We speculate that in both models increased endothelin gene
expression would favor the development of focal glomerulo-
sclerosis and contribute to the progression of glomerular dis-
ease either by inducing a local vasoconstriction as well as by
stimulating mesangial cell proliferation [7] and excessive syn-
thesis of mesangial matrix proteins [101.
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Fig. 3. Correlation between urinary endothelin excretion and % of
sclerolic glomeruli in rats (N = 30) with remnant kidney studied at day
7,30, 60 and 120 after the surgical procedure. r = 0.76; P < 0.01.
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